NIH RePORTER Risk After Schedule Policy/Career
Decision brief
Answer first · skim in under a minute
President Trump issued an executive order stripping civil service protections from approximately 8,000 NIH employees, including senior grants officials. The move makes the grants process more susceptible to political influence and threatens the stability of NIH RePORTER and eRA Commons systems.
Executive Order 14410 of June 3, 2026 implements Schedule Policy/Career transfers across the federal workforce. For sponsors that depend on NIH RePORTER and eRA Commons, the operational risk is slower grant administration and less predictable policy-influencing staffing—not a change to NIH science peer review written into the order itself.
Contents10 sections
Key Takeaways
- EO 14410 (June 3, 2026) places listed policy-influencing roles into Schedule Policy/Career and gives agencies 7 days to notify affected staff.
- EO 14171 (January 20, 2025) reinstated Schedule Policy/Career rules that exclude covered career posts from standard adverse-action procedures.
- NIH invests nearly $48 billion and awards about 82% of funding extramurally—so grant-ops friction hits industry pipelines fast.
- Monitor NIH RePORTER and eRA Commons; do not treat secondary headcount estimates as official EO text.
What did EO 14410 change for federal grant agencies?
On June 3, 2026, the White House issued Executive Order 14410, “Implementing Schedule Policy/Career in the Excepted Service.” The Federal Register published the text on June 10, 2026.
Section 5 places appendix-listed positions into Schedule Policy/Career. Agency heads must notify covered officers or employees within 7 days and conform agency records. The order amends Civil Service Rules and builds on EO 14171.
Primary text: EO 14410 on GovInfo (FR June 10, 2026).
How does Schedule Policy/Career relate to Schedule F?
EO 14171 of January 20, 2025 reinstated EO 13957 and renamed Schedule F as Schedule Policy/Career. Covered employees remain career hires filled on merit, but they sit outside ordinary chapter 75 adverse-action and appeal paths.
The order states employees need not personally support the President’s politics. They must faithfully implement administration policies, or face dismissal grounds under the order’s terms.
Primary text: EO 14171 on GovInfo.
Why NIH RePORTER and eRA Commons matter to pharma
NIH RePORTER is the public module for searching NIH-funded projects and linked publications and patents. Sponsors use it for academic partner diligence, competitive landscaping, and award tracking.
eRA Commons is the electronic Research Administration portal for applications, peer review, and award management. Staff churn or reassignment in policy-influencing roles can create backlogs even when science review criteria stay the same.
Tool links: NIH RePORTER and eRA Commons (era.nih.gov).
Scale of NIH funding that sits behind the tools
NIH reports it invests most of a nearly $48 billion budget in medical research. About 82% of NIH funding is awarded for extramural research.
That extramural stream runs largely through almost 50,000 competitive grants to more than 300,000 researchers at more than 2,500 universities, medical schools, and other research institutions.
- Nearly $48 billion NIH budget scale (NIH Office of Budget page)
- About 82% extramural share of NIH funding
- Almost 50,000 competitive grants across 2,500-plus institutions
Source: NIH Budget overview.
What OPM’s 2026 rule adds to accountability rules
On February 6, 2026, the Office of Personnel Management published a final rule on performance, accountability, and responsiveness in the civil service (RIN 3206-AO80).
The rule authorizes agencies to move policy-influencing positions into Schedule Policy/Career as at-will excepted posts while keeping them career jobs filled on a nonpartisan basis. It also requires internal policies against prohibited personnel practices.
Primary text: OPM final rule PDF on GovInfo.
What remains unproven about NIH-specific headcount
Secondary media reports have circulated round-number estimates of NIH staff reclassified under Schedule Policy/Career. EO 14410’s public Federal Register text places appendix-listed positions into the schedule. It does not, in the portions reviewed for this article, publish a verified NIH-wide headcount of “about 8,000.”
Until HHS or NIH publishes an official count, treat those figures as unverified. Track agency notices, RePORTER refresh cadence, and eRA processing times instead of repeating unsourced totals.
Related NovaPharma coverage
- FDA gene therapy guidance: what BD teams need to know
- FDA approves lumasiran for PH1
- Trump annual physical: pharma implications
Frequently Asked Questions
What did Executive Order 14410 change on June 3, 2026?
EO 14410 placed designated policy-influencing positions into Schedule Policy/Career of the excepted service and directed agency heads to notify covered employees within 7 days and update agency records.
How does NIH RePORTER fit into pharma monitoring after the order?
NIH RePORTER is the public search tool for NIH-funded projects, publications, and patents. Pharma teams use it to track award status, institute funding patterns, and partner activity when staffing or policy shifts may slow updates.
What should companies with active NIH grants do next?
Confirm award status in NIH RePORTER, watch eRA Commons for submission and review delays, document grant terms for administrative change risk, and map contingency funding if review timelines stretch.
Primary Sources
Sources & references 1 primary sources
Sources verified at publication. See our editorial policy and data sources.
This article follows our editorial standards. Report a correction via editorial contact.
